Quick Answer
Instil Bio, Inc. reported Stockholders Equity of $113.87 million for fiscal year 2025.
Instil Bio, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $113.87M | -32.8% |
| 2024 | $169.44M | -25.0% |
| 2023 | $225.83M | -37.9% |
| 2022 | $363.61M | -34.5% |
| 2021 | $555.20M | +1502.1% |
| 2020 | -$39.60M | -474.6% |
| 2019 | -$6.89M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $120.42M | -31.7% | -8.5% |
| June 30, 2025 | $131.67M | -32.5% | -9.1% |
| March 31, 2025 | $144.91M | -29.6% | -14.5% |
| December 31, 2024 | $169.44M | -25.0% | -3.9% |
| September 30, 2024 | $176.33M | -24.7% | -9.6% |
| June 30, 2024 | $195.02M | -34.2% | -5.3% |
| March 31, 2024 | $205.83M | -33.9% | -8.9% |
| December 31, 2023 | $225.83M | -37.9% | -3.5% |
- Instil Bio, Inc. showed a decrease of -32.8% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, Instil Bio, Inc.’s stockholders equity has grown by 1752.1% (from -$6.89 million to $113.87 million).
- The most recent figure is from Instil Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: